What does HER2 status mean for Multiple Myeloma treatment
HER2 Status and Multiple Myeloma: Important Clarification
I appreciate this question because it highlights an important distinction in cancer care. HER2 status is NOT typically relevant for multiple myeloma treatment planning.
Here's why:
HER2 Testing in Different Cancers
HER2 (human epidermal growth factor receptor 2) is a protein that's important in specific cancers, particularly:
- Breast cancer - where HER2 testing is standard and guides treatment decisions
- Gastric (stomach) cancer - where HER2 status helps determine therapy options
- Some other solid tumors
According to NCCN Guidelines for breast cancer, HER2 testing determines whether patients benefit from HER2-targeted therapies like trastuzumab (Herceptin) or pertuzumab. However, multiple myeloma is a blood cancer with a completely different biology.
What Actually Matters for Myeloma Treatment
According to the NCCN Guidelines for Patients: Multiple Myeloma, the biomarkers that DO guide treatment decisions include:
- Chromosomal abnormalities (detected by FISH testing) - such as deletions of chromosome 17, translocations involving chromosome 14, or amplification of chromosome 1q21
- M protein type (IgG, IgA, IgM, kappa, or lambda)
- Free light chain levels
- Bone marrow involvement percentage
These findings help determine whether your myeloma is standard-risk or high-risk, which influences treatment intensity and approach.
Questions to Ask Your Myeloma Team
If you have multiple myeloma, consider asking:
- What is my specific cytogenetic risk profile? (This is what matters for myeloma)
- What is my M protein type and level?
- Have I had FISH testing to look for high-risk chromosomal changes?
- Based on these findings, what treatment approach do you recommend?
If you have a different cancer type (like breast cancer) AND myeloma, that would be unusual and would require specialized discussion with your care team about each cancer separately.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Multiple Myeloma — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated May 18, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Multiple Myeloma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Multiple Myeloma patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Multiple Myeloma
- Can I travel by airplane during Multiple Myeloma treatment
- How do I request workplace accommodations for Multiple Myeloma treatment
- How is Multiple Myeloma treatment different for young adults
- What is partial response vs complete response in Multiple Myeloma treatment
- How do I rebuild my immune system after Multiple Myeloma treatment
- What causes swelling and lymphedema after Multiple Myeloma treatment
- How do I deal with fear of recurrence after Multiple Myeloma treatment
- How much does Multiple Myeloma treatment cost and what does insurance cover